Alembic Pharma Raises Rs 150 Crore via NCDs

Drug firm Alembic Pharmaceuticals Tuesday said it has raised Rs 150 crore through the allotment of non-convertible debentures (NCDs) on private placement basis. These NCDs carry a coupon rate of 8.37 percent per annum and are proposed to be listed on NSE. “The NCD Committee of Alembic Pharmaceuticals Ltd at its meeting held today has allotted 1,500, 8.37 percent unsecured listed rated redeemable NCDs of Rs 1,000,000…aggregating to Rs 150 crore under tranche III,” the company said in a regulatory filing. Date of maturity of these NCDs is March 18, 2022. – Business Standard

Share this:

Related Post

Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.